Remacemide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Remacemide" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
1st place
1st place
18th place
17th place
621st place
380th place
low place
low place
low place
low place
low place
low place
447th place
338th place
102nd place
76th place
low place
low place
405th place
256th place
low place
low place
low place
low place

astrazeneca.com

doi.org

fda.gov

  • FDA (2009-05-05). "Cumulative List of all Products that have received Orphan Designation". FDA. Archived from the original (excel document) on April 8, 2013. Retrieved 28 April 2012.

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

highbeam.com

business.highbeam.com

huginonline.com

reports.huginonline.com

huntington-study-group.org

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

parkinson-study-group.org

semanticscholar.org

api.semanticscholar.org

thepharmaletter.com

ukmi.nhs.uk

web.archive.org

  • FDA (2009-05-05). "Cumulative List of all Products that have received Orphan Designation". FDA. Archived from the original (excel document) on April 8, 2013. Retrieved 28 April 2012.
  • "remacemide () UKMi New Drugs Online Database". Archived from the original on 21 May 2013. Retrieved 2 May 2012.
  • "remacemide AstraZeneca discontinued, Europe, USA, Canada (epilepsy)". R & D Focus Drug News. March 15, 2004. Archived from the original on May 18, 2013. Retrieved 2 May 2012.
  • "Completed Clinical Trials". Huntington Study Group. 2010. Archived from the original on 28 June 2012. Retrieved 29 April 2012.
  • "Clinical Trials and Observational Studies in Progress". Huntington Study Group. 2010. Archived from the original on 18 May 2009. Retrieved 29 April 2012.
  • "Clinical Trials in Progress - Parkinson Study Group". Archived from the original on 11 September 2011. Retrieved 2 May 2012.

zenodo.org